Clinical Trial Update: Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating phlebotomy to reduce hepatocellular carcinoma risk in patients with compensated alcoholic cirrhosis and iron overload has been terminat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Cirrhosis
• Hepatocellular Carcinoma
• Iron Overload

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Alcoholic Cirrhosis, Iron Overload | Phase 3 | Status: TERMINATED